MedTech Dive April 5, 2024
The deal comes just over a week after The Wall Street Journal reported that the companies were discussing a merger.
Editor’s note: This story is developing and will be updated.
Johnson & Johnson has agreed to acquire Shockwave Medical for approximately $13.1 billion including cash acquired, the companies announced Friday morning. The deal values Shockwave at $335 per share.
J&J said in a statement that Shockwave will expand its “cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD).”
Both companies’ boards...
Today's Sponsors
Today's Sponsor